To explore the epigenetic basis of ETS1 activation during metastasis, we analyzed enhancer and promoter landscapes from an epigenomic dataset comparing nonmalignant esophageal tissues, primary ESCC, and LN metastases23. The gene discussed is ETS1; the disease is esophageal squamous cell carcinoma.